Dr Hannah Leese receives IChemE medal for her work in early detection of disease
Image credit: IChemE
The CSCT academic received the Nicklin Medal, an award to recognise talented chemical engineering researchers.
An early career researcher, experts in food bioprocessing and a dedicated volunteer are among the 25 chemical engineers across 14 medals and prizes recognised by the Institution of Chemical Engineers (IChemE) for their exceptional contribution to the profession in industry and academia.
The list of 2022 prize winners was announced on 14 February. Among the winners was Dr Hannah Leese, early-career CSCT and C3Bio researcher who received the Nicklin Medal, an award introduced in 2014 to recognise talented chemical engineering researchers. The award criteria stipulate that nominees must have no more than ten years of postgraduate research experience and should have produced international quality research outputs. Dr Leese was awarded the medal for her ground-breaking work on developing technologies for early detection of disease, including sepsis and ovarian cancer.
The Medals and Prizes Committee were delighted to note that medals recognising achievements by early and mid-career chemical engineers all received a high number of nominations.
Dr Hannah Leese, CSCT academic
Alexandra Meldrum, IChemE Vice President Learned Society and Chair of the Medals and Prizes Committee, said:
“Our medals programme recognises the outstanding achievement of chemical engineers and the great work that IChemE members carry out through volunteer roles. A new initiative this year, is that the judging criteria consider sustainability, impact and alignment with progress toward a net-zero economy and the UN Sustainable Development Goals. Our winners are great leaders and role models in the chemical engineering profession. Congratulations to all the winners!”
The medal winners will be awarded their prizes during virtual webinars taking place throughout the year and these will be advertised on the IChemE website www.icheme.org/medals.
Comments are closed here.